Acute suppression by PGF2 alpha on LH, epinephrine and fluoride stimulation of adenylate cyclase in rat luteal tissue. 1979

M I Khan, and S Rosberg

Injection of PGF2 alpha (250 microgram/rat) 15 min prior to isolation of corpora lutea (CL) from PMSG treated immature rats significantly reduced the LH stimulation of adenylate cyclase in CL membranes. The LH stimulation did not return to normal even 24 h after PGF2 alpha injection. A transient decrease in epinephrine and fluoride stimulation of AC was also observed, the response returning to normal 6-12 h after PGF2 alpha treatment. In vitro incubation of whole isolated CL with 0.005 micrometer or higher concentrations of PGF2 alpha markedly reduced the LH and fluoride stimulation of AC in the CL membranes. Exposure of CL to PGF2 alpha for 15 min in vitro reduced the LH and fluoride response. The results are discussed in relation to the suppressive action of PGF2 alpha on LH receptors in CL, and a mechanism is proposed to explain the discrepancy in time relation between our results and the LH receptor studies. The proposed mechanism might also explain the transient decrease in epinephrine and fluoride stimulation of AC.

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D003338 Corpus Luteum The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE. Corpora Lutea,Lutea, Corpora
D004092 20-alpha-Dihydroprogesterone A biologically active 20-alpha-reduced metabolite of PROGESTERONE. It is converted from progesterone to 20-alpha-hydroxypregn-4-en-3-one by the 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE in the CORPUS LUTEUM and the PLACENTA. Dihydroprogesterone,20 alpha-Dihydroprogesterone,20 alpha-Hydroxy-4-Pregnen-3-One,20 alpha-Hydroxyprogesterone,20-alpha-Hydroxyprogesterone,20alpha-Hydroxypregn-4-Ene-3-One,Pregn-4-en-3-one, 20-alpha-hydroxy-,20 alpha Dihydroprogesterone,20 alpha Hydroxy 4 Pregnen 3 One,20 alpha Hydroxyprogesterone,20-alpha-hydroxy- Pregn-4-en-3-one,20alpha Hydroxypregn 4 Ene 3 One,Pregn 4 en 3 one, 20 alpha hydroxy
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D005260 Female Females

Related Publications

M I Khan, and S Rosberg
October 1976, FEBS letters,
M I Khan, and S Rosberg
November 1977, Biokhimiia (Moscow, Russia),
M I Khan, and S Rosberg
January 1979, Advances in experimental medicine and biology,
M I Khan, and S Rosberg
August 1975, Life sciences,
M I Khan, and S Rosberg
April 1978, Journal of cyclic nucleotide research,
Copied contents to your clipboard!